Does serial multiparametric cardiac magnetic resonance (CMR) identify early doxorubicin-induced cardiotoxicity in a large animal model?
Serial multiparametric CMR can identify anthracycline-induced cardiotoxicity at an early, reversible disease stage in a large animal model.
BACKGROUND: Anthracycline-induced cardiotoxicity is a major clinical problem, and early cardiotoxicity markers are needed. OBJECTIVES: The purpose of this study was to identify early doxorubicin-induced cardiotoxicity by serial multiparametric cardiac magnetic resonance (CMR) and its pathological correlates in a large animal model. METHODS: mapping (including extracellular volume ECV quantification). A control group was sacrificed after the initial CMR. RESULTS: prolongation occurs at a reversible disease stage. CONCLUSIONS: mapping, ECV, or LV motion defects. The occurrence of these changes at a reversible disease stage shows the clinical potential of this CMR marker for tailored anthracycline therapy.
Galán‐Arriola et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: